Display options
Cite
Amen T, Kaganovich D. Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization. Microb Cell. 2016;3(3):97-100doi: 10.15698/mic2016.03.482.
Amen, T., & Kaganovich, D. (2016). Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization. Microbial cell (Graz, Austria), 3(3), 97-100. https://doi.org/10.15698/mic2016.03.482
Amen, Triana, and Kaganovich, Daniel. "Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization." Microbial cell (Graz, Austria) vol. 3,3 (2016): 97-100. doi: https://doi.org/10.15698/mic2016.03.482
Amen T, Kaganovich D. Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization. Microb Cell. 2016 Mar 03;3(3):97-100. doi: 10.15698/mic2016.03.482. PMID: 28362007; PMCID: PMC5349019.
Copy Download .nbib Format: NLM
Share it on

Microb Cell. 2016 Mar 03;3(3):97-100. doi: 10.15698/mic2016.03.482.

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization.

Microbial cell (Graz, Austria)

Triana Amen, Daniel Kaganovich

Affiliations

  1. Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel. ; Alexander Grass Center for Bioengineering, Hebrew University of Jerusalem, Jerusalem, Israel.
  2. Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.

PMID: 28362007 PMCID: PMC5349019 DOI: 10.15698/mic2016.03.482

[No abstract available.]

Keywords: Alzheimer’s; FDA; amyloid beta; drug; screen; yeast

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

References

  1. Biochemistry. 2000 Sep 5;39(35):10831-9 - PubMed
  2. Nat Neurosci. 2001 Sep;4(9):887-93 - PubMed
  3. Nature. 2002 Apr 4;416(6880):535-9 - PubMed
  4. Neuroscience. 2002;110(2):199-211 - PubMed
  5. Hum Mol Genet. 2004 Jan 15;13(2):159-70 - PubMed
  6. Science. 2003 Dec 5;302(5651):1772-5 - PubMed
  7. Nat Neurosci. 2005 Jan;8(1):79-84 - PubMed
  8. Nat Genet. 2006 Jan;38(1):24-6 - PubMed
  9. Science. 2006 Sep 15;313(5793):1604-10 - PubMed
  10. BMC Biol. 2006 Sep 26;4:32 - PubMed
  11. J Neurosci. 2007 Dec 26;27(52):14459-69 - PubMed
  12. Nature. 2008 Aug 28;454(7208):1088-95 - PubMed
  13. Alzheimers Dement. 2007 Jul;3(3):186-91 - PubMed
  14. Cell. 2009 Dec 11;139(6):1157-69 - PubMed
  15. Dis Model Mech. 2010 Mar-Apr;3(3-4):194-208 - PubMed
  16. Annu Rev Neurosci. 2011;34:185-204 - PubMed
  17. JAMA. 2011 Apr 27;305(16):1655; author reply 1655-6 - PubMed
  18. PLoS Biol. 2011 Apr;9(4):e1000614 - PubMed
  19. Science. 2011 Dec 2;334(6060):1241-5 - PubMed
  20. Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338 - PubMed
  21. Science. 2013 Nov 22;342(6161):983-7 - PubMed
  22. Science. 2013 Nov 22;342(6161):979-83 - PubMed
  23. Aging Cell. 2014 Feb;13(1):165-74 - PubMed
  24. PLoS Genet. 2014 May 08;10(5):e1004302 - PubMed
  25. Cell Rep. 2014 Jun 12;7(5):1560-1576 - PubMed
  26. Rare Dis. 2013 Mar 27;1:e24420 - PubMed
  27. Microb Cell. 2016 Jan 20;3(2):53-64 - PubMed
  28. Appl Pathol. 1984;2(6):357-69 - PubMed
  29. Nat Med. 1995 Dec;1(12):1291-6 - PubMed
  30. Acta Neuropathol. 1999 Feb;97(2):113-8 - PubMed

Publication Types